http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0827150-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5736c85c1929ce4e9775e836a65d6c05 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C381-00 |
| filingDate | 1994-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53ea94a91584730e3f525baca431073a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8cb62915db6a980384ad86fe8beb599 |
| publicationDate | 1996-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0827150-A |
| titleOfInvention | Process for producing spiro (oxirane-2,3 ') quinuclidine |
| abstract | (57) [Summary] [Object] The present invention provides spiro (oxirane-2, which is useful as an intermediate for therapeutic agents for diseases of the central nervous system of mammals, etc.). 3 ') relates to a process for producing quinuclidine, which is suitable for industrial use by using economically advantageous raw materials. [Constitution] quinuclidin-3-one, a basic substance, Trimethylsulfoxonium methylsulfate or trimethylsulfonium methylsulfate is reacted to produce spiro (oxirane-2,3 ') quinuclidine. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014507536-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001199985-A |
| priorityDate | 1994-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.